When recruited to the bone, tumor cells with CTNND1 reduction exhibit a stronger ability to survive by secreting more GM-CSF and IL-8, which contributed to the infiltration of immature myeloid cells, especially neutrophils, impairing proliferation and cytotoxicity of CTLs. The gene discussed is CTNND1; the disease is neoplasm.